Use of a local anaesthetic/antiseptic formulation for the treatment of lambs experimentally infected with orf virus

Lacasta, Delia (Universidad de Zaragoza) ; Ríos, Marina ; Ruiz de Arcaute, Marta (Universidad de Zaragoza) ; Ortín, Aurora (Universidad de Zaragoza) ; Ramos, Juan José (Universidad de Zaragoza) ; Villanueva-Saz, Sergio (Universidad de Zaragoza) ; Tejedor, María Teresa (Universidad de Zaragoza) ; Ruiz, Héctor (Universidad de Zaragoza) ; Borobia, Marta (Universidad de Zaragoza) ; Reina, Ramsés ; Gómez, Alex (Universidad de Zaragoza) ; Navarro, Teresa (Universidad de Zaragoza) ; Windsor, Peter Andrew
Use of a local anaesthetic/antiseptic formulation for the treatment of lambs experimentally infected with orf virus
Resumen: Contagious ecthyma is a highly transmissible eruptive viral disease of the skin and mucosa of sheep and goats distributed worldwide. The treatment of orf lesions is usually based on the use of antiseptics and antibiotics for the management of presumptive secondary infections, increasing risks of antimicrobial resistance. The wound dressing formulation Tri-Solfen® (TS) containing two local anaesthetics (lignocaine and bupivacaine), adrenaline and an antiseptic (cetrimide) in a gel formulation has been demonstrated to reduce suffering and enhance recovery in cattle and buffalo with oral and skin lesions due to foot-and-mouth disease virus infection and reduced the orf viral load in lambs. In the present study, experimental infection with the orf virus was conducted in 50 newborn lambs and 25 animals were treated after the presence of the first lesions with TS and repeated three days later. Daily clinical examination, haematological, serological, biomolecular and post-mortem analyses were conducted during 34 days after treatment. Results indicated that treatment had no effect on weight gain and clinical progression of the lesions. It was determined that seroconversion after experimental infection occurs 34 days after infection and suggested that the deep basal epithelial location of the orf lesions may have prevented the therapy from having altered the clinical course.
Idioma: Inglés
DOI: 10.3390/ani13182962
Año: 2023
Publicado en: Animals 13, 18 (2023), 2962 [14 pp.]
ISSN: 2076-2615

Factor impacto JCR: 2.7 (2023)
Categ. JCR: VETERINARY SCIENCES rank: 16 / 167 = 0.096 (2023) - Q1 - T1
Categ. JCR: AGRICULTURE, DAIRY & ANIMAL SCIENCE rank: 10 / 80 = 0.125 (2023) - Q1 - T1

Factor impacto CITESCORE: 4.9 - Animal Science and Zoology (Q1) - Veterinary (all) (Q1)

Factor impacto SCIMAGO: 0.698 - Veterinary (miscellaneous) (Q1) - Animal Science and Zoology (Q1)

Financiación: info:eu-repo/grantAgreement/ES/DGA-FSE/Construyendo Aragón 2016–2020-A15-17R
Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Área Genética (Dpto. Anatom.,Embri.Genét.Ani.)
Área (Departamento): Área Sanidad Animal (Dpto. Patología Animal)
Área (Departamento): Área Medicina y Cirugía Animal (Dpto. Patología Animal)


Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.


Exportado de SIDERAL (2024-11-22-12:12:17)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos



 Registro creado el 2023-12-15, última modificación el 2024-11-25


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)